JP2011520930A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520930A5
JP2011520930A5 JP2011509869A JP2011509869A JP2011520930A5 JP 2011520930 A5 JP2011520930 A5 JP 2011520930A5 JP 2011509869 A JP2011509869 A JP 2011509869A JP 2011509869 A JP2011509869 A JP 2011509869A JP 2011520930 A5 JP2011520930 A5 JP 2011520930A5
Authority
JP
Japan
Prior art keywords
compound
formula
butanol
base
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011509869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520930A (ja
JP5458093B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002997 external-priority patent/WO2009141040A2/en
Publication of JP2011520930A publication Critical patent/JP2011520930A/ja
Publication of JP2011520930A5 publication Critical patent/JP2011520930A5/ja
Application granted granted Critical
Publication of JP5458093B2 publication Critical patent/JP5458093B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011509869A 2008-05-23 2009-04-24 3,6−ジヒドロ−1,3,5−トリアジン誘導体の合成法 Expired - Fee Related JP5458093B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08009483.2 2008-05-23
EP08009483 2008-05-23
PCT/EP2009/002997 WO2009141040A2 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives

Publications (3)

Publication Number Publication Date
JP2011520930A JP2011520930A (ja) 2011-07-21
JP2011520930A5 true JP2011520930A5 (enExample) 2012-05-24
JP5458093B2 JP5458093B2 (ja) 2014-04-02

Family

ID=40791625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011509869A Expired - Fee Related JP5458093B2 (ja) 2008-05-23 2009-04-24 3,6−ジヒドロ−1,3,5−トリアジン誘導体の合成法

Country Status (21)

Country Link
US (1) US20110124860A1 (enExample)
EP (1) EP2300444B1 (enExample)
JP (1) JP5458093B2 (enExample)
KR (1) KR101618198B1 (enExample)
CN (1) CN102036970A (enExample)
AU (1) AU2009250149B2 (enExample)
BR (1) BRPI0912512B1 (enExample)
CA (1) CA2725011A1 (enExample)
CY (1) CY1117855T1 (enExample)
DK (1) DK2300444T3 (enExample)
EA (1) EA018921B1 (enExample)
ES (1) ES2571793T3 (enExample)
HR (1) HRP20160414T1 (enExample)
HU (1) HUE027532T2 (enExample)
IL (1) IL209198A (enExample)
MX (1) MX2010012741A (enExample)
PL (1) PL2300444T3 (enExample)
RS (1) RS54736B1 (enExample)
SI (1) SI2300444T1 (enExample)
WO (1) WO2009141040A2 (enExample)
ZA (1) ZA201009160B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2646422T3 (pl) 2010-12-01 2015-12-31 Poxel Rozdział enancjomerów pochodnych triazyny z zastosowaniem kwasu winowego
CN105753801B (zh) * 2016-03-25 2018-06-01 浙江工业大学 一种均三嗪类化合物的制备方法
JP2020536121A (ja) 2017-10-02 2020-12-10 ポクセルPoxel 駆出率が保持された心不全を治療する方法
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
CN114681464B (zh) * 2020-12-28 2024-07-09 南京理工大学 二甲双胍类似物在制备脑缺血再灌注损伤预防和治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
AU2003289375A1 (en) * 2002-12-17 2004-07-09 Hamari Chemicals, Ltd Novel 2,4-diamino-1,3,5-triazine derivative
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind

Similar Documents

Publication Publication Date Title
JP2011520930A5 (enExample)
JP5889299B2 (ja) 1−置換−3−フルオロアルキル−ピラゾール−4−カルボン酸のエステルの調製方法
JP2010502715A5 (enExample)
JP2018529687A5 (enExample)
JP2009527517A5 (enExample)
JP2009543861A5 (enExample)
JP2015500335A5 (enExample)
RU2016133187A (ru) Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина
JP2009235096A5 (enExample)
JP2009544663A5 (enExample)
RU2018106948A (ru) Способ получения замещенных производных 3-(2-анилино-1-циклогексил -1н-бензимидазол-5-ил)пропановой кислоты
RU2016135762A (ru) Способ получения (r)-1,1,3-триметил-4-аминоиндана
ATE510833T1 (de) Verfahren zur herstellung von hochreinem almotriptan
AR092793A1 (es) Procedimiento para la preparacion de derivados de isoxazolina azetidina quirales como agentes antiparasitarios
JP2017505286A5 (enExample)
RU2018130327A (ru) Улучшенный способ получения осимертиниба (azd9291) или его соли и "анилин-azd9291" или его соли
JP5458093B2 (ja) 3,6−ジヒドロ−1,3,5−トリアジン誘導体の合成法
CY1108804T1 (el) Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
JP2008540414A5 (enExample)
JP2020530016A5 (enExample)
WO2002051781A1 (fr) Procede permettant de preparer un compose d'halohydrine optiquement actif
JP2008247919A5 (enExample)
RU2009115852A (ru) Способ получения абакавира
WO2008067781B1 (en) A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
CN103387547B (zh) 一种制备嘧螨胺的方法